At a glance
ClinicalIndex Comparison RecordN/ACompleted· 25 enrolled
Drug / intervention
EnBrace HRdietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
EnBrace HR for Depression Treatment and Prevention in Women Trying to Conceive and Early Pregnancy
In Brief
A clinical study evaluating EnBrace HR for Depressive Disorder and Pregnancy. Completed, enrolled 25 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the effectiveness of the EnBrace HR prenatal supplement in preventing depression in women with a history of depression who have decided to stop taking antidepressants during their pregnancy, or treating women who are currently in a depressive episode while pregnant or planning pregnancy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepressive Disorder, Pregnancy
CountriesUnited States
CollaboratorsJayMac Pharmaceuticals, LLC
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 2016
Enrollment StartJan 2017
Primary CompletionMay 2018
Study CompletionNov 2018
TodayJul 2026
First PostedFeb 8, 2016
Enrollment StartJan 24, 2017
Primary CompletionMay 15, 2018
Study CompletionNov 30, 2018
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 10.4 years ago
Interventions
EnBrace HRdietary
Prescription folate prenatal supplement with other dietary ingredients; one multiphasic soft gelatin capsule 1x/day for 12 week study